Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Absorption of enteric and non-enteric coated prednisolone tablets.

Literature DB >> 1233990

Absorption of enteric and non-enteric coated prednisolone tablets.

Abstract

1. Relative rates of absorption of enteric and non-enteric preparations of prednisolone were measured in five renal transplant recipients. 2. The absorption of the enteric coated preparation is delayed and the peak plasma concentration is much lower than that attained using the same dose of the uncoated material. 3. The therapeutic implications of these observations are discussed.

Entities: Chemical

Mesh：

Substances：

Year: 1975 PMID： 1233990 PMCID： PMC1402595 DOI： 10.1111/j.1365-2125.1975.tb02777.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

8 in total

1. A comparison of the growth suppressive effect of cortisone, prednisone, and other adrenal cortical hormones.

Authors: T E VAN METRE; W A NIERMANN; L J ROSEN
Journal: J Allergy Date: 1960 Nov-Dec

2. Prevention of peptic ulceration during corticosteroid therapy.

Authors: H F WEST
Journal: Br Med J Date: 1959-10-10

3. Renal transplantation in children. Analysis of 25 consecutive transplants in 19 recipients.

Authors: B Hulme; J R Kenyon; K Owen; M Snell; J F Mowbray; K A Porter; S J Starkie; H Muras; W S Peart
Journal: Arch Dis Child Date: 1972-08 Impact factor: 3.791

4. Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function.

Authors: M E Carter; V H James
Journal: Ann Rheum Dis Date: 1972-09 Impact factor: 19.103

5. Alternate-day prednisone therapy after renal transplantation.

Authors: W P Reed; Z J Lucas; R Cohn
Journal: Lancet Date: 1970-04-11 Impact factor: 79.321

6. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors: B E Murphy
Journal: J Clin Endocrinol Metab Date: 1967-07 Impact factor: 5.958

7. Cadaveric renal transplantation. An analysis of 65 cases.

Authors: P Pletka; J R Kenyon; M Snell; S L Cohen; K Owen; J F Mowbray; B Hulme; A E Thompson; K A Porter; D A Leigh; W S Peart
Journal: Lancet Date: 1969-01-04 Impact factor: 79.321

8. A semi-automated fluorimetric procedure for the determination of plasma corticosteroids.

Authors: J Townsend; V H James
Journal: Steroids Date: 1968-04 Impact factor: 2.668

8 in total

15 in total

Review 9. Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors: J G Gambertoglio; W J Amend; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1980-02

10. A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets.

Authors: C G Adair; O McCallion; J C McElnay; M G Scott; B A Hamilton; J P McCann; C F Stanford; D P Nicholls
Journal: Br J Clin Pharmacol Date: 1992-05 Impact factor: 4.335

Absorption of enteric and non-enteric coated prednisolone tablets.

1. A comparison of the growth suppressive effect of cortisone, prednisone, and other adrenal cortical hormones.

2. Prevention of peptic ulceration during corticosteroid therapy.

3. Renal transplantation in children. Analysis of 25 consecutive transplants in 19 recipients.

4. Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function.

5. Alternate-day prednisone therapy after renal transplantation.

6. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

7. Cadaveric renal transplantation. An analysis of 65 cases.

8. A semi-automated fluorimetric procedure for the determination of plasma corticosteroids.

1. Plasma prednisolone levels in man following administration in plain and enteric-coated forms.

2. Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

3. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

4. Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.

5. Bioavailability of prednisolone tablets.

6. Use of enteric coated prednisolone in Crohn's disease.

Review 7. Oral controlled release dosage forms. A review.

8. Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients.

Review 9. Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

10. A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets.